Reyataz for HIV/AIDS

Browse eMedTV's wide range of articles related to reyataz for hiv/aids including topics such as reyataz and pregnancy, reyataz warnings and precautions, and reyataz dosage. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Reyataz for HIV/AIDS

Reyataz is a prescription drug that is approved to treat HIV and AIDS. This eMedTV article explains how Reyataz helps prevent HIV from multiplying, describes when and how to take the drug, and lists side effects that may occur with treatment.

Potentially serious Reyataz side effects include depression, jaundice, and arrhythmia. As this eMedTV page explains, however, side effects of the drug are generally minor. Common (and usually mild) side effects include fever, diarrhea, and nausea.

Reyataz is used for the treatment of HIV and AIDS. This segment from the eMedTV Web site discusses Reyataz uses in more detail, including information on whether the drug is used in children or for off-label purposes.

For people who have never taken HIV drugs, the recommended Reyataz dosage is 400 mg once daily. This eMedTV page also offers Reyataz dosing guidelines for people who have previously used HIV drugs and for those who are also taking Sustiva or Viread.

Warfarin, antacids, and pimozide are drugs that may interact negatively with Reyataz. Drug interactions, as this eMedTV resource explains, could reduce the effectiveness of the medications and increase your risk for developing serious side effects.

Before taking Reyataz, let your doctor know if you have diabetes, arrhythmia, or a history of kidney stones. This eMedTV page includes other Reyataz warnings and precautions, including a list of certain people who should not take the drug.

In reported cases of Reyataz overdose, people experienced an irregular heart rhythm and jaundice. As this eMedTV article explains, treatment for an overdose may include giving certain medicines, "pumping the stomach," and supportive care.

Reyataz is generally considered safe for use during pregnancy. This page from the eMedTV Web site provides more information on Reyataz and pregnancy, including an explanation of when a doctor may prescribe the drug to a pregnant woman.

Women who are taking Reyataz are typically advised to avoid breastfeeding. This eMedTV Web page contains more information on Reyataz and breastfeeding, and explains why it may be dangerous for a woman with HIV to breastfeed.

Reyataz will not be available in generic form until April 2017 at the earliest. This part of the eMedTV archives discusses when a generic version may be available and explains why it may be dangerous to buy so-called "generic Reyataz" products.